LUCA Science Announces the Opening of a New Subsidiary in the UK and Expansion on the Collaboration With the University of Oxford on the Development of Novel Mitochondrial Therapeutics
TOKYO--(BUSINESS WIRE)--LUCA Science (Tokyo, Japan), a biotechnology company pioneering a novel class of mitochondrial therapeutics has announced the expansion of its international operations, with the establishment of a new wholly-owned subsidiary company in the United Kingdom. LUCA Science UK will focus on research collaborations with the University of Oxford using LUCA Science’s proprietary Mitochondria therapy in advancing treatment of intra-uterine growth restriction (IUGR) for mothers and ...
